Port site metastatic disease in ovarian carcinoma
Conclusion
In all cases, port-site metastatic disease developed rapidly and was clinically suspected at the time of definitive surgery. We recommend that consideration be given towards removing port sites when performing cytoreductive surgery for gynaecological malignancy.
Source: Irish Journal of Medical Science - Category: Journals (General) Source Type: research
More News: Adenocarcinoma | Biomedical Science | Cancer & Oncology | Carcinoma | General Medicine | Incontinence | Laparoscopy | OBGYN | Ovarian Cancer | Ovaries | Pain | Pain Management | Science